DE3580616D1 - Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. - Google Patents

Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.

Info

Publication number
DE3580616D1
DE3580616D1 DE8585303874T DE3580616T DE3580616D1 DE 3580616 D1 DE3580616 D1 DE 3580616D1 DE 8585303874 T DE8585303874 T DE 8585303874T DE 3580616 T DE3580616 T DE 3580616T DE 3580616 D1 DE3580616 D1 DE 3580616D1
Authority
DE
Germany
Prior art keywords
mitomycine
derivatives
production
pharmaceutical preparations
preparations containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585303874T
Other languages
English (en)
Inventor
Kunikatsu Shirahata
Motomichi Kono
Yutaka Saito
Masaji Kasai
Makoto Morimoto
Tadashi Ashizawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Application granted granted Critical
Publication of DE3580616D1 publication Critical patent/DE3580616D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
DE8585303874T 1984-06-01 1985-05-31 Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. Expired - Lifetime DE3580616D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59112428A JPS60255789A (ja) 1984-06-01 1984-06-01 マイトマイシン誘導体,その製造法および抗腫瘍剤

Publications (1)

Publication Number Publication Date
DE3580616D1 true DE3580616D1 (de) 1991-01-03

Family

ID=14586392

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585303874T Expired - Lifetime DE3580616D1 (de) 1984-06-01 1985-05-31 Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.

Country Status (4)

Country Link
US (1) US4691024A (de)
EP (1) EP0163550B1 (de)
JP (1) JPS60255789A (de)
DE (1) DE3580616D1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866180A (en) * 1984-02-24 1989-09-12 Bristol-Myers Company Amino disulfide thiol exchange products
ZA86308B (en) * 1985-02-25 1986-11-26 Bristol Myers Co In-vial deposition of 7-(dimethylaminomethylene)amino-9a-methoxy-mitosane
DE3750846T2 (de) * 1986-08-29 1995-05-11 Kyowa Hakko Kogyo Kk Mitomycin-derivate.
JPS63150282A (ja) * 1986-12-13 1988-06-22 Kyowa Hakko Kogyo Co Ltd マイトマイシン誘導体
US5599903A (en) * 1992-04-03 1997-02-04 Terrapin Technologies, Inc. Glutathione analogs and paralog panels comprising glutathione mimics
ZA886812B (en) * 1987-11-23 1989-07-26 Bristol Myers Co Anti-tumor prodrugs
US5075454A (en) * 1990-03-08 1991-12-24 Bristol-Myers Squibb Company 7-(diphenylmethyl)oxy-9a-methoxymitosane
US5175303A (en) * 1990-03-08 1992-12-29 Bristol-Myers Squibb Company Preparation of 7-(diphenylmethyl)oxy-9A-methoxymitosane
US5556942A (en) * 1991-04-29 1996-09-17 Terrapin Technologies, Inc. Glutathione S-transferase-activated compounds
US5908919A (en) * 1993-10-01 1999-06-01 Terrapin Technologies Urethane mediated, GST specific molecular release systems
US7875612B2 (en) 2001-04-24 2011-01-25 Purdue Research Foundation Folate mimetics and folate-receptor binding conjugates thereof
ATE426414T1 (de) 2002-05-15 2009-04-15 Endocyte Inc Vitamin-mitomycin-konjugate
TWI367096B (en) 2003-01-27 2012-07-01 Endocyte Inc Vitamin-receptor binding drug delivery conjugates and pharmaceutical compositions
WO2006012527A1 (en) 2004-07-23 2006-02-02 Endocyte, Inc. Bivalent linkers and conjugates thereof
CN101175757B (zh) 2005-03-16 2012-11-14 恩多塞特公司 蝶酸及其缀合物的合成和纯化
KR20130113543A (ko) 2005-08-19 2013-10-15 엔도사이트, 인코포레이티드 복수-약제 리간드 공액체
US20080280937A1 (en) * 2005-08-19 2008-11-13 Christopher Paul Leamon Ligand Conjugates of Vinca Alkaloids, Analogs, and Derivatives
EP1850255B1 (de) * 2006-04-28 2013-09-25 BlackBerry Limited System und Verfahren zur Verwaltung mehrerer Chipkartensitzungen
WO2008101231A2 (en) * 2007-02-16 2008-08-21 Endocyte, Inc. Methods and compositions for treating and diagnosing kidney disease
EP2481427A1 (de) 2007-03-14 2012-08-01 Endocyte, Inc. Folat-Tubulysin Konjugate
US9877965B2 (en) 2007-06-25 2018-01-30 Endocyte, Inc. Vitamin receptor drug delivery conjugates for treating inflammation
RU2523909C2 (ru) 2007-06-25 2014-07-27 Эндосайт, Инк. Конъюгаты, содержащие гидрофильные спейсеры линкеров
JP2010536790A (ja) 2007-08-17 2010-12-02 パーデュー・リサーチ・ファウンデーション Psma結合性リガンド−リンカー結合体及び使用方法
US9187521B2 (en) 2007-10-25 2015-11-17 Endocyte, Inc. Tubulysins and processes for preparing
US9951324B2 (en) 2010-02-25 2018-04-24 Purdue Research Foundation PSMA binding ligand-linker conjugates and methods for using
US10080805B2 (en) 2012-02-24 2018-09-25 Purdue Research Foundation Cholecystokinin B receptor targeting for imaging and therapy
US20140080175A1 (en) 2012-03-29 2014-03-20 Endocyte, Inc. Processes for preparing tubulysin derivatives and conjugates thereof
EA201590622A1 (ru) 2012-10-16 2015-10-30 Эндосайт, Инк. Конъюгаты для доставки лекарственного средства, содержащие не встречающиеся в природе аминокислоты, и способы применения
BR112015011118B1 (pt) 2012-11-15 2022-12-13 Endocyte, Inc Conjugado; composição farmacêutica; e uso de um conjugado
TN2016000137A1 (en) 2013-10-18 2017-10-06 Deutsches Krebsforsch Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer.
US10188759B2 (en) 2015-01-07 2019-01-29 Endocyte, Inc. Conjugates for imaging
CA2979527A1 (en) 2015-03-13 2016-09-22 Endocyte, Inc. Conjugates of pyrrolobenzodiazepine (pbd) prodrugs for treating disease
US11566044B2 (en) 2017-07-26 2023-01-31 The University Of Queensland Disulfide bond containing compounds and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54122797A (en) * 1978-03-16 1979-09-22 Kyowa Hakko Kogyo Co Ltd Preparation of 7-demethoxy-7-aminomitomycin b derivatives
JPS5545322A (en) * 1978-09-27 1980-03-31 Kyowa Hakko Kogyo Co Ltd Preparation of mitomycins by fermentation
US4268676A (en) * 1979-12-05 1981-05-19 University Patents, Inc. Mitomycin analogs
NZ199617A (en) * 1981-05-15 1985-08-30 University Patents Inc Azirino(2',3',:3,4)pyrrolo(1,2-a)indole-4,7-dione derivatives and pharmaceutical compositions
EP0116208B1 (de) * 1982-12-07 1988-03-30 Kyowa Hakko Kogyo Co., Ltd. Mitomycin-Analoge
JPS59104386A (ja) * 1982-12-07 1984-06-16 Kyowa Hakko Kogyo Co Ltd マイトマイシン誘導体
JPS59175493A (ja) * 1983-03-25 1984-10-04 Kyowa Hakko Kogyo Co Ltd マイトマイシン誘導体
US4803212A (en) * 1983-04-11 1989-02-07 Bristol-Myers Company Amino disulfides

Also Published As

Publication number Publication date
EP0163550A2 (de) 1985-12-04
EP0163550B1 (de) 1990-11-22
JPS60255789A (ja) 1985-12-17
EP0163550A3 (en) 1987-05-20
US4691024A (en) 1987-09-01

Similar Documents

Publication Publication Date Title
DE3580616D1 (de) Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE109145T1 (de) Heterozyklische acylaminothiazolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE37028T1 (de) Cephalosporinverbindungen, ihre herstellung, pharmazeutische praeparate und eingangsprodukte.
ATE111452T1 (de) Tetrahydronaphthalin- und indanderivate, deren herstellung und verwendung für pharmazeutische präparate.
ATE24490T1 (de) Phenyl-1-piperidino-2-propanol-derivate, ihre herstellung und diese enthaltende arzneimittel.
DE3669315D1 (de) Phenoxyalkylaminopyrimidinderivate, deren herstellung und diese enthaltende insektizide und akarizide zusammensetzungen.
DE3679920D1 (de) Spiro-3-heteroazolidinverbindungen und ihre salze, ihre herstellung und diese enthaltende pharmazeutische mittel.
DE3877406D1 (de) Benzothiazolinon-derivate, ihre herstellung und pharmazeutische zusammensetzung.
ATE13298T1 (de) Azepinderivate, ihre herstellung und diese enthaltende arzneimittel.
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
DE3576118D1 (de) Pharmazeutische praeparate.
DE3776620D1 (de) 3-propenylcephemderivate, ihre herstellung, zwischenverbindungen, pharmazeutische praeparate und anwendung.
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DE3867086D1 (de) Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
DE3681856D1 (de) Pharmazeutische 2-oxopyrrolidinverbindungen, ihre salze und ihre herstellung.
ATE32882T1 (de) Phenylnonatetraensaeurederivate, ihre herstellung und pharmazeutische praeparate mit diesen derivaten.
DE3685743T2 (de) Anthracyclinderivate, ihre verwendung als antitumorsubstanzen und ihre herstellung.
IT8722218A0 (it) Ftalazino derivati ad attivita'farmaceutica.
DE3689036D1 (de) Lankacidinderivate und ihre Herstellung.
ATA263487A (de) Neue verbindungen, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
DE3761379D1 (de) 1,3-propandiaminderivate, ihre herstellung und sie enthaltende arzneimittel.
DE3670083D1 (de) Pharmazeutische pyrrolizidinverbindungen und -zusammensetzungen und ihre herstellung.
DE3773128D1 (de) Cyclopentanaether, ihre herstellung und pharmazeutische formulierung.
DE216605T1 (de) Lymphokin, dessen herstellung und verwendungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee